Verastem (VSTM) Consolidated Net Income (2011 - 2026)

Verastem's (VSTM) quarterly Consolidated Net Income came in at -$44.5 million in Q1 2026, little changed year-on-year from -$44.5 million in Q1 2025, and down 1487.92% quarter-over-quarter from $3.2 million in Q4 2025.

Verastem (VSTM) Consolidated Net Income (2011 - 2026) Analysis & Trends

Verastem's Consolidated Net Income history runs 16 years deep, the most recent figure standing at -$44.5 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income changed 0.11% year-over-year to -$44.5 million in Q1 2026; TTM through Mar 2026 was -$139.5 million, a 5.54% decrease from a year earlier, with the FY2025 full-year figure at -$165.5 million, down 26.66% from the prior year.
  • Consolidated Net Income fell to -$44.5 million in Q1 2026 per VSTM's latest filing, from $3.2 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $3.2 million in Q4 2025 and bottomed at -$54.0 million in Q2 2025.
  • The 5-year median for Consolidated Net Income is -$22.0 million (2022), against an average of -$27.4 million.
  • Biggest YoY gain for Consolidated Net Income was 110.02% in 2025; the steepest drop was 192.7% in 2025.
  • Year by year, Consolidated Net Income stood at -$16.8 million in 2022, then plunged by 76.25% to -$29.6 million in 2023, then retreated by 7.96% to -$32.0 million in 2024, then soared by 110.02% to $3.2 million in 2025, then tumbled by 1487.92% to -$44.5 million in 2026.
  • Per Business Quant, the three latest VSTM Consolidated Net Income figures stand at -$44.5 million (Q1 2026), $3.2 million (Q4 2025), and -$44.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 66,831.58 Bn 66,831.30 Bn - -37.09 Mn
2 Nanobiotix 1,916.61 Bn 1,916.55 Bn - -
3 Akari Therapeutics 976.78 Bn 976.78 Bn - -14.46 Mn
4 BeOne Medicines 471.48 Bn 466.69 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.78 Bn 114.53 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 69.87 Bn 61.12 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 63.06 Bn 63.06 Bn - -26.94 Mn
8 Argenx Se 55.78 Bn 50.60 Bn 1.41 Bn 362.00 Mn
9 Alnylam Pharmaceuticals 37.54 Bn 34.53 Bn 959.66 Mn 205.99 Mn
10 Verastem 615.80 Mn 417.97 Mn 15.90 Mn -44.46 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -44.46 Mn
Dec 31, 2025 3.20 Mn
Sep 30, 2025 -44.28 Mn
Jun 30, 2025 -53.95 Mn
Mar 31, 2025 -44.41 Mn
Dec 31, 2024 -31.97 Mn
Sep 30, 2024 -37.35 Mn
Jun 30, 2024 -18.43 Mn
Mar 31, 2024 -31.23 Mn
Dec 31, 2023 -29.61 Mn
Sep 30, 2023 -20.19 Mn
Jun 30, 2023 -20.29 Mn
Mar 31, 2023 -19.14 Mn
Dec 31, 2022 -16.80 Mn
Sep 30, 2022 -18.17 Mn
Jun 30, 2022 -21.96 Mn
Mar 31, 2022 -17.19 Mn
Dec 31, 2021 -16.48 Mn
Sep 30, 2021 -24.95 Mn
Jun 30, 2021 -34.78 Mn